Caroline Morrison
Psychiatry · Naperville, ILNPI 1285707935
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,175 of the $43,781 with a category attached, or 75.8%. Alkermes, Inc. accounts for 82.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $18,027 and has fallen 57.7% since, to $7,632 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $243.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$36K
- AbbVie$6K
- Lilly USA, LLC$271
- Johnson & Johnson$177
- Otsuka America Pharmaceutical, Inc.$172
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$141
- plus $963 from 17 others
What the payments were for
- Consulting fees$4,63011%
- Speaking & faculty fees$33,17576%
- Travel & lodging$2,5906%
- Food & beverage$3,3328%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 74 | $35,928 |
| AbbVie(2 entities) | 22 | $6,129 |
| Lilly USA, LLC | 9 | $271 |
| Johnson & Johnson | 7 | $177 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $141 |
| Lundbeck LLC | 8 | $133 |
| Vivus LLC | 1 | $125 |
| Sunovion Pharmaceuticals Inc. | 5 | $88 |
| Corium, LLC | 6 | $86 |
| Novo Nordisk | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Avanir Pharmaceuticals, Inc. | 4 | $65 |
| Axsome Therapeutics, Inc. | 4 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Bausch Health US, LLC | 2 | $34 |
| Itamar Medical Inc | 1 | $19 |
| Biogen | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,781 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 16 | $23,272 |
| MounjaroTirzepatide | 22 | $23,000 |
| TrintellixVortioxetine Hydrobromide | 17 | $16,440 |
| Lisdexamfetamine Dimesylate | 18 | $3,863 |
| Bupropion XlBupropion Hcl | 184 | $3,353 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 31 | $2,410 |
| Duloxetine Hcl | 124 | $1,897 |
| Atomoxetine Hcl | 14 | $1,648 |
| Fluoxetine Hcl | 53 | $1,166 |
| Escitalopram Oxalate | 51 | $993 |
| Methylphenidate ErMethylphenidate Hcl | 20 | $915 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 54 | $773 |
| Buspirone Hcl | 32 | $772 |
| Lamotrigine | 40 | $658 |
| Sertraline Hcl | 62 | $619 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Olanzapine | $271 | $23,52940 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $172 | $23,27216 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $70 | $16,44017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Naperville
- Sandeep GaonkarNaperville$31K
- Philip JanicakNaperville$17K
- Petrit NdrioNaperville$16K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.